Apramycin

Generic Name: Apramycin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₄₁N_₅O_₁₁

CAS Number: 37321-09-8

Unique Ingredient Identifier: 388K3TR36Z

Background: Apramycin is an aminoglycoside antibiotic and has a bactericidal action against many gram-negative bacteria. Apramycin is a structurally unique antibiotic that contains a bicyclic sugar moiety and a monosubstituted deoxystreptamine. It is not approved for use in humans.

Indication: For the treatment of bacterial infections in animals.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Safety of Intravenous Apramycin in Adults

Phase 1

Completed

Conditions: Bacterial Infection

Interventions: Drug: Apramycin (EBL-1003)

First Posted Date: 2022-10-21

Last Posted Date: 2024-12-10

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 16

Registration Number: NCT05590728

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC - Knoxville, Knoxville, Tennessee, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy